Earnings History Data for Cyclo Therapeutics (CYTH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Cyclo Therapeutics

Cyclo Therapeutics Inc. is a clinical-stage biotechnology company. It develops cyclodextrin-based products for the treatment of disease. The company's Trappsol(R) Cyclo(TM), an orphan drug designated product primarily in the United States and Europe, is in ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. Cyclo Therapeutics Inc., formerly known as CTD Holdings Inc., is based in ALACHUA, Fla.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
15-05-2024 PM CYTH Cyclo Therapeutics 40.00 -0.15 -0.20 0.00 Cyclo Therapeutics reports Q1 results
[5/16/2024 9:19 AM]
1.37 -0.06 
1.38 -0.03 
0.89 - 2.57 51,951 30,000 4,338
15-11-2021 AH CYTH Cyclo Therapeutics, Inc. 46.16 -0.60 0.00 0.00 Cyclo Therapeutics EPS beats by $0.07, beats on revenue
[11/15/2021 5:08 PM]
7.29 0.0 
7.80 0.51 
3.40 - 17.75 1,169,010 40,000 1,287,247